Table 3.
Process Indicator | Preimplementation Quality Rate (%) (n =300)* | Postimplementation Quality Rate (%) (n =300)* | P-Value for Pre/Post Comparison† |
---|---|---|---|
Subjective assessment | 49.3 | 48.7 | .866 |
Exam for pain complaint | 26.0 | 26.0 | .924 |
Other orders to assess pain | 11.7 | 8.3 | .171 |
New pain prescription | 8.7 | 11.0 | .331 |
Change existing pain meds | 6.7 | 4.3 | .208 |
Any other form of treatment | 11.7 | 13.7 | .461 |
Follow-up plan made | 10.0 | 8.7 | .567 |
Composite evaluation | 50.0 | 50.3 | .867 |
Composite treatment | 26.0 | 28.3 | .517 |
Any attention to pain | 52.0 | 53.0 | .802 |
Variables have the potential to be affirmative in 100% of patients, regardless of the presence or absence of pain.
P >.05 for all comparisons between pre and post groups using random effects (to account for physician clustering) logistic regression analysis; post hoc analysis indicated that a minimal difference of 6% to 10% could be detected between the groups.